As of December 31, 2019, Thomson Medical Group Ltd. carries a market capitalization of 1.69B, placing it among publicly traded companies globally. Its enterprise value stands at 1.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.69B |
| Enterprise Value | 1.69B |
Thomson Medical Group Ltd.'s next confirmed earnings release is scheduled for February 5, 2027.
| Earnings Date | 2/5/2027 |
As of December 31, 2019, Thomson Medical Group Ltd. has 26.44B shares outstanding.
| Shares Outstanding | 26.44B |
These figures are as of December 31, 2019.
| PS Ratio | 7.34 |
| P/FCF Ratio | 158.10 |
| P/OCF Ratio | 24.73 |
As of December 31, 2019, Thomson Medical Group Ltd. trades at an EV/EBITDA multiple of 30.53 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 45.12 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Thomson Medical Group Ltd. trades at an EV/FCF ratio of 104.62, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.69B versus a market cap of 1.69B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 7.36 |
| EV / EBITDA | 30.53 |
| EV / EBIT | 45.12 |
| EV / FCF | 104.62 |
These figures are as of December 31, 2019.
| Interest Coverage | 2.16 |
Over the twelve months ended December 31, 2019, Thomson Medical Group Ltd. recorded 11.52M in income tax expense. That works out to an effective tax rate of 78.57, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 14.66M, leaving -1.67M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 11.52M |
| Effective Tax Rate | 78.57 |
As of the close on November 17, 2026, Thomson Medical Group Ltd.'s stock has declined approximately 23.73% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.05.
| 52-Week Price Change | -23.73% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.05 |
Over the twelve months ended December 31, 2019, Thomson Medical Group Ltd. generated 229.82M in revenue and converted that into -1.67M in net income, yielding earnings per share of 0.00. EBITDA reached 55.43M, while operating income came in at 37.50M.
| Revenue | 229.82M |
| Gross Profit | 181.98M |
| Operating Income | 37.50M |
| Pretax Income | 14.66M |
| Net Income | -1.67M |
| EBITDA | 55.43M |
| EBIT | 37.50M |
Thomson Medical Group Ltd. produced 68.20M in operating cash flow over the twelve months ended December 31, 2019. After subtracting -57.53M in capital expenditures, free cash flow totaled 10.67M - equivalent to 0.00 per share.
| Operating Cash Flow | 68.20M |
| Capital Expenditures | -57.53M |
| Free Cash Flow | 10.67M |
Over the twelve months ended December 31, 2019, Thomson Medical Group Ltd. posted a gross margin of 79.18, reflecting its pricing power and cost economics. The operating margin of 16.32 and net profit margin of -0.73 provide insight into operational efficiency.
| Gross Margin | 79.18 |
| Operating Margin | 16.32 |
| Pretax Margin | 6.38 |
| Profit Margin | -0.73 |
| EBITDA Margin | 24.12 |
Over the twelve months ended December 31, 2019, Thomson Medical Group Ltd. paid dividends of 0.00 per share. The dividend payout ratio of 116.19 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.63, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.39, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Thomson Medical Group Ltd. shareholders.
| Payout Ratio | 116.19 |
| Shareholder Yield | 1.39 |
| FCF Yield | 0.63 |
Thomson Medical Group Ltd.'s most recent stock split took place on August 21, 2009 with a 23:28 split ratio.
| Last Split Date | 8/21/2009 |
| Split Ratio | 23:28 |
Already premium?